These studies indicate a positive trend of an increasing number of SGLT2i representatives, confirming their effectiveness in the treatment of HF, which directly translates into the expansion of the list of available drugs.
← all excerpts
Heart Failure in the Modern Era: A Narrative Overview of Recent Research from 2022-2025.
1
—
—